| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | 1 | — | — | — | — | — | — |
| Sell | — | 1 | 1 | — | 1 | — | — | — | 1 | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2029 | ‡‡‡‡‡ |
|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 3.81 |
—
—
—
|
| 2025 | 3.71 |
—
—
—
—
|
| 2024 | 3.36 |
—
—
—
—
|
| 2023 | 3.05 |
—
—
—
—
|
| 2022 | 2.73 |
—
—
—
—
|
| 2021 | 2.43 |
—
—
—
—
|
| 2020 | 2.23 |
—
—
—
—
|
| 2019 | 2.05 |
—
—
—
—
|
| 2018 | 1.70 |
—
—
—
—
|
| 2017 | 1.39 |
—
—
—
—
|
| 2016 | 1.26 |
—
—
—
—
|
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash | 252.30 | 304.40 | 561.50 | 402.90 |
| Receivables | 974.00 | 1,065.60 | 1,077.10 | 1,129.40 |
| Inventory | 34.00 | — | — | — |
| Other | 166.20 | 170.90 | 178.50 | 215.80 |
| 1,392.50 | 1,540.90 | 1,817.10 | 1,748.10 |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Payables | 1,019.50 | 1,194.40 | 1,112.80 | 1,138.20 |
| ST’ Debt | 1,178.50 | — | 499.30 | — |
| Other | 199.80 | 227.40 | 249.10 | 276.60 |
| 2,397.80 | 1,421.80 | 1,861.20 | 1,414.80 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 1,589.40 | 1,713.90 | 1,953.60 | 2,219.90 |
7,476.80
|
| ’25 | 1,422.90 | 1,589.20 | 1,811.70 | 2,065.30 |
6,889.10
|
| ’24 | 1,431.10 | 1,405.00 | 1,726.50 | 1,944.20 |
6,506.80
|
| ’23 | 1,283.30 | 1,292.90 | 1,645.70 | 1,839.00 |
6,060.90
|
| ’22 | 1,192.90 | 1,259.60 | 1,533.70 | 1,722.90 |
5,709.10
|
| ’21 | 1,017.40 | 1,054.90 | 1,389.80 | 1,531.60 |
4,993.70
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 42.30 | 324.80 | 301.10 | 677.40 |
1,345.60
|
| ’25 | (125.50) | 236.70 | 360.40 | 699.70 |
1,171.30
|
| ’24 | (62.00) | 189.80 | 207.40 | 721.00 |
1,056.20
|
| ’23 | (204.50) | 123.10 | 175.50 | 729.20 |
823.30
|
| ’22 | (135.40) | 40.80 | 80.70 | 457.40 |
443.50
|
| ’21 | (44.20) | 127.50 | 106.20 | 450.60 |
640.10
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 12.70 | 305.90 | 272.40 | 642.00 |
1,233.00
|
| ’25 | (157.60) | 213.90 | 336.80 | 663.30 |
1,056.40
|
| ’24 | (76.40) | 167.80 | 167.20 | 684.60 |
943.20
|
| ’23 | (218.10) | 103.60 | 161.80 | 700.80 |
748.10
|
| ’22 | (151.30) | 27.50 | 55.50 | 438.70 |
370.40
|
| ’21 | (50.20) | 100.70 | 85.80 | 421.10 |
557.40
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 1.40 | 2.42 | 2.36 | 3.44 |
9.60
|
| ’25 | 0.68 | 1.20 | 2.05 | 3.16 |
7.10
|
| ’24 | 0.76 | 0.59 | 1.79 | 2.72 |
5.86
|
| ’23 | 0.42 | 0.48 | 1.67 | 2.72 |
5.30
|
| ’22 | 0.57 | 0.40 | 1.49 | 2.09 |
4.55
|
| ’21 | 0.56 | 0.48 | 1.40 | 2.20 |
4.65
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 131.35 | 132.70 | 188.30 | 212.33 | 133.83 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 183.34 | 207.29 | 237.96 | 271.91 | 224.51 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14,300 | 14,700 | 14,600 | 15,000 | 16,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.40 | 0.41 | 0.45 | 0.46 | 0.47 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,709.10 | 6,060.90 | 6,506.80 | 6,889.10 | 7,476.80 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.89% | 29.46% | 29.72% | 31.02% | 31.78% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 672.20 | 794.90 | 877.40 | 1,058.70 | 1,445.80 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.77% | 13.12% | 13.48% | 15.37% | 19.34% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 539.10 | 630.60 | 698.10 | 839.50 | 1,124.30 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 464.00 | 425.00 | 477.90 | 498.10 | 508.40 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 48.92 | 51.49 | 55.28 | 58.83 | 64.29 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 4.62 | 5.36 | 5.93 | 7.17 | 9.67 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.80 | 6.99 | 8.97 | 10.00 | 11.57 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.63) | (0.64) | (0.96) | (0.98) | (0.97) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.17 | 6.36 | 8.01 | 9.02 | 10.60 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.44 | 19.04 | 18.42 | 22.67 | 24.42 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 116.70 | 117.70 | 117.70 | 117.10 | 116.30 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.92 | 30.90 | 33.15 | 33.94 | 14.13 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.91 | 3.22 | 3.56 | 4.13 | 2.13 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.67 | 8.70 | 10.67 | 10.72 | 5.61 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.55 | 3.74 | 4.03 | 4.52 | 2.58 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 61.29 | 31.99 | 29.04 | 30.65 | 16.16 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 443.50 | 823.30 | 1,056.20 | 1,171.30 | 1,345.60 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (73.10) | (75.20) | (113.00) | (114.90) | (112.60) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 370.40 | 748.10 | 943.20 | 1,056.40 | 1,233.00 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.00 | (1,005.30) | 119.10 | (44.10) | 333.30 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,838.00 | 3,413.20 | 3,355.10 | 3,252.30 | 3,254.60 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,613.30 | 3,160.90 | 3,050.70 | 2,690.80 | 2,851.70 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,919.10 | 2,240.60 | 2,168.20 | 2,655.10 | 2,840.50 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.62% | 7.69% | 8.47% | 10.00% | 12.86% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.58% | 10.83% | 12.18% | 13.90% | 14.28% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.92% | 30.32% | 31.67% | 34.81% | 40.91% | ‡‡‡‡‡ | — | — |
ROE
|
Broadridge Financial Solutions (BR) has engineered impressive growth, with revenue surging 109% from $2.9 billion in 2016 to $6.1 billion in 2023, powered by its ironclad dominance in proxy voting, investor communications, and the game-changing $1.9 billion Itiviti acquisition that expanded wealth management tech. Productivity shines through rising revenue per employee and expanding margins—gross to 29.7% and EBT to 13.5% in 2024—fueling EPS growth to a projected $7.17 in 2025. Yet, this steady engine hums amid decelerating revenue, capex spikes denting free cash flow, and a balance sheet still burdened by debt that tripled post-acquisition, now easing but amplifying risks in a volatile fintech landscape.
The real red flag? Insiders are fleeing: zero buys and over $80 million in executive sales since early 2025, led by the CEO and President dumping tens of thousands of shares at peaks near $230-250. With the stock trading 41% below consensus targets as of February 2026, premium multiples (PS 3.6x, PB 10.7x, EV/FCF 30x) scream vulnerability, decoupling from glowing forecasts of 7.5% revenue CAGR and EPS to $9.15 by 2026.
Analysts chase the dream of perpetual expansion via regulatory tailwinds and synergies, implying 23-48% upside. But contrarians hear alarm bells—insider exodus echoing pre-2022 stalls, fintech disruptors like AI and blockchain looming, and no buys signaling doubt. Is Broadridge a compounding machine or a top in disguise? Dive deeper to uncover if the growth narrative holds or if caution wins.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.